NCT02215096 2020-10-22Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate CancerGlaxoSmithKlinePhase 1 Completed37 enrolled 26 charts
NCT01458067 2018-07-24A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) DeficiencyGlaxoSmithKlinePhase 1 Completed30 enrolled